HDAC7 promotes cardiomyocyte proliferation by suppressing myocyte enhancer factor 2
Journal of Molecular Cell Biology · 2025
DOI: 10.1093/jmcb/mjae044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2025. Verfasst von Jihyun Jang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Cell Proliferation, MEF2 Transcription Factors, Histone Deacetylases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Postnatal mammalian cardiomyocytes (CMs) rapidly lose proliferative capacity and exit the cell cycle to undergo further differentiation and maturation. Cell cycle activation has been a major strategy to stimulate postnatal CM proliferation, albeit achieving modest effects. One impediment is that postnatal CMs may need to undergo dedifferentiation before proliferation, if not simultaneously. Here, we report that overexpression of Hdac7 in neonatal mouse CMs results in significant CM dedifferentiation and proliferation. Mechanistically, we show that histone deacetylase 7 (HDAC7)-mediated CM proliferation is contingent on dedifferentiation, which is accomplished by suppressing myocyte enhance factor 2 (MEF2). Hdac7 overexpression in CM shifts the chromatin state from binding with MEF2, which favors the transcriptional program toward differentiation, to binding with AP-1, which favors the transcriptional program toward proliferation. Furthermore, we found that HDAC7 interacts with minichromosome maintenance complex components to initiate cell cycle progression. Our findings reveal that HDAC7 promotes CM proliferation by its dual action on CM dedifferentiation and proliferation, uncovering a potential new strategy for heart regeneration/repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cardiovascular Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.
- Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43205, USA.
- Bioinformatics Core Unit (BCU), Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.
- Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Proteomics Facility, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Jang, J., Bentsen, M., Bu, J., Chen, L., Campos, A. R., Looso, M., & Li, D. (2025). HDAC7 promotes cardiomyocyte proliferation by suppressing myocyte enhancer factor 2. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjae044
Vancouver
Jang J, Bentsen M, Bu J, Chen L, Campos AR, Looso M, et al. HDAC7 promotes cardiomyocyte proliferation by suppressing myocyte enhancer factor 2. Journal of Molecular Cell Biology. 2025. doi:10.1093/jmcb/mjae044
BibTeX
@article{Jang2025,
author = {Jang, Jihyun and Bentsen, Mette and Bu, Jin and Chen, Ling and Campos, Alexandre Rosa and Looso, Mario and Li, Deqiang},
title = {HDAC7 promotes cardiomyocyte proliferation by suppressing myocyte enhancer factor 2},
journal = {Journal of Molecular Cell Biology},
year = {2025},
doi = {10.1093/jmcb/mjae044}
}
EUVIMED